Position in INCY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,670,761
+$322,467 QoQ
Shares Held
23,560
-5.6% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DUMONT & BLAKE INVESTMENT ADVISORS LLC holds $2,693,161 across 2 Biotechnology names. INCY ranks #1 (99.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
This page
|
23,560 | $2,670,761 | |
| 2 | AUTL |
Autolus Therapeutics plc
|
14,000 | $22,400 |
All Filings in INCY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,670,761 | 23,560 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $2,348,294 | 24,950 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,519,721 | 25,511 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $2,171,644 | 25,606 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $1,756,367 | 25,791 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $1,549,232 | 25,586 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $1,768,537 | 25,605 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $1,706,635 | 25,819 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $3,112,715 | 51,348 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $527,770 | 9,264 | Shares | Sole | 2024-04-17 | |
| No filing history on record for this holder in this stock. | ||||||